WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'8801 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 15'2311 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 2'083  2'081  2'079  2'077  2'076  2'035  1'996  1'924 
Births 23  23  23  23  23  26  35  41 
Surviving infants 23  23  23  23  23  26  34  38 
Pop. less than 5 years 118  118  116  115  113  136  174  189 
Pop. less than 15 years 348  349  350  353  355  461  523  574 
Female 15-49 years 513  517  520  523  527  527  515  498 

Number of reported cases

(Click for retrospective incidence data for The former Yugoslav Republic of Macedonia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  19  116  36 
Mumps
ChartChart
  32  45  52  60  441 
Pertussis
ChartChart
  13  21 
Polio*
ChartChart
 
Rubella
ChartChart
  87 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for The former Yugoslav Republic of Macedonia)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   89  97  99  94  99  97  97 
DTP1 2009  98  MICS   89  97  97  98  98  97  98 
DTP3 2009  95  MICS   89  91  95  91  95  98  95 
DTP4          83  89  91  93 
IPV1          97  97  98 
HepB_BD          98  98  99  98 
HepB3          91  94  92  97  97 
Hib3 2009  95  MICS   89  91  94  89  94  97 
JapEnc         
MCV1          83  82  89  93  96  97 
MCV2          97  93  93  96  96  95 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2009  97  MICS   89  91  95  92  96  98  96 
Rota1         
RotaC         
RCV1          83  82  89  93  96 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for The former Yugoslav Republic of Macedonia)
BCG
ChartChart
  97  99  94  99  97  97 
DTP1
ChartChart
  97  97  98  98  99  98 
DTP3
ChartChart
  91  95  91  95  98  95 
HepB3
ChartChart
  91  94  92  97  97 
HepB_BD
ChartChart
  98  98  98  98  98 
Hib3
ChartChart
  91  94  89  94  97 
IPV1
  97  97  98 
MCV1
ChartChart
  83  82  89  93  96  97 
MCV2
ChartChart
  97  93  93  96  96  95 
PCV3
 
Pol3
  91  95  92  96  98  96 
RCV1
ChartChart
  83  82  89  93  96  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 31  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 6
From 50 to 79% 3
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepBIPV 2, 6 months; Yes
DTaPHibIPV 3.5, 18 months; Yes
DTwP 4 years; Yes
HepB_Pediatric birth; Yes
HPV 12 years; +6 months; Yes females only
Influenza_Adult >65 years; Yes and adults with chronic illness, pregnant women, health care workers
Influenza_Pediatric 0-14 years; Yes and children with chronic illness
MMR 12 months; 6 years; Yes
OPV 7, 14 years; Yes
Td 7, 14 years; Yes
TT 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2012-2020  2012-2020  2012-2020  2012-2020  2012-2020  2012-2020   
Nº of districts with microplans that include activities to raise immunization coverage number 31  31  31  31  31     

System performance

Total Nº districts in country number 31  31  31  31  31  31  31 
Nº districts with DTP3 coverage >=80% number 30  31  30  31  31  31  31 
% of districts with DTP3 coverage >=80% From 0 to 100% 97  100  97  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 10  15  23  30  28  29 
% of districts with MCV1 coverage >=95% From 0 to 100% 32  26  48  74  97  90  94 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes    Yes  Yes  No  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No    Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.